Pacira BioSciences, Inc. PCRX Preferred Stock, Shares Outstanding

Preferred Stock, Shares Outstanding at other companies

General DynamicsGD

0—

Apollo Global ManagementAPO

28.7M0.0%

Mondelez InternationalMDLZ

0—

L3Harris TechnologiesLHX

0—

Bank of AmericaBAC

4M+4.8%

Phillips 66PSX

0—

Other financials

Income statement

See full

Revenue$177.4M+5.0%

Gross profit$141.0M+4.7%

Operating income$6.9M+247%

Net income$2.9M-39.4%

EPS (diluted)$0.07-30.0%

Balance sheet

See full

Cash & equivalents$144.3M-49.1%

Total debt$411.2M+15.3%

Total equity$653.9M-18.1%

Total assets$1.2B-23.8%

Cash flow

See full

Operating cash flow$25.7M-27.6%

CapEx$2.7M-68.1%

Free cash flow$23.0M-14.7%

Valuation

See full

Market cap$958.91M-14.5%

Enterprise value$1.23B+2.6%

P/E186.6×—

P/S1.3×-0.3×

Profitability

See full

Gross margin79.3%+1.7pp

Operating margin3.3%—

Net margin0.7%—

FCF margin18.1%-4.6pp

Returns & leverage

See full

Return on equity0.7%—

Debt / equity0.6×+0.2×

Current ratio4.7×+2.3×

Where this comes from

Reported directly by Pacira BioSciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.

The official record: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacira BioSciences, Inc.'s preferred stock, shares outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pacira BioSciences, Inc.'s preferred stock, shares outstanding?: Pacira BioSciences, Inc. (PCRX) reported preferred stock, shares outstanding of $0 in Q1 2026.